JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Spina, M. B.
Right arrow Articles by Cohen, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spina, M. B.
Right arrow Articles by Cohen, G.

Exposure of striatal [corrected] synaptosomes to L-dopa increases levels of oxidized glutathione [published erratum appears in J Pharmacol Exp Ther 1989 Jan;248(1):478]

MB Spina and G Cohen

Department of Neurology, Mount Sinai School of Medicine, City University of New York, New York.

Incubation of striatal synaptosomes with L-dopa and glucose in either the presence or absence of 10 microM reserpine resulted in a rise in the level of oxidized glutathione (GSSG) within the isolated tissue pellet. The rise in GSSG was concentration dependent in the range of 0.04-1.0 mM L-dopa. With 1.0 mM L-dopa in the presence of reserpine, the GSSG level was elevated by 7.0 +/- 0.7 pmol/mg original striatal tissue, which corresponds to an increase of 38.0 +/- 4.5% compared with control. The rise in GSSG reflects an oxidative stress. The oxidation of dopamine by monoamine oxidase generates H2O2, which is normally detoxified by glutathione peroxidase to yield GSSG. In the presence of clorgyline or pargyline (two monoamine oxidase inhibitors), the rise in GSSG was suppressed by 88-92%, as was the formation of DOPAC. NSD-1055 and carbidopa (two inhibitors of dopa-decarboxylase) also significantly suppressed (50-60%) the rise in GSSG. These data show that the synthesis of dopamine from L-dopa, with subsequent catabolism of dopamine, can evoke a significant rise in the level of GSSG, which reflects the oxidant stress associated with monoamine oxidase activity.

Volume 247, Issue 2, pp. 502-507, 11/01/1988
Copyright © 1988 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 NeurologyHome page
R. A. Hauser and T. A. Zesiewicz
Clinical trials aimed at detecting neuroprotection in Parkinson's disease
Neurology, May 23, 2006; 66(10_suppl_4): S58 - S68.
[Abstract] [Full Text]

Home page
 Hum Exp ToxicolHome page
A. E Khalifa
Pro-oxidant activity of zuclopenthixol in vivo: differential effect of the drug on brain oxidative status of scopolamine-treated rats
Human and Experimental Toxicology, September 1, 2004; 23(9): 439 - 445.
[Abstract] [PDF]

Home page
 J. Neurosci.Home page
T. B. Sherer, R. Betarbet, C. M. Testa, B. B. Seo, J. R. Richardson, J. H. Kim, G. W. Miller, T. Yagi, A. Matsuno-Yagi, and J. T. Greenamyre
Mechanism of Toxicity in Rotenone Models of Parkinson's Disease
J. Neurosci., November 26, 2003; 23(34): 10756 - 10764.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
B. Drukarch, C. A. M. Jongenelen, E. Schepens, C. H. Langeveld, and J. C. Stoof
Glutathione Is Involved in the Granular Storage of Dopamine in Rat PC12 Pheochromocytoma Cells: Implications for the Pathogenesis of Parkinson's Disease
J. Neurosci., October 1, 1996; 16(19): 6038 - 6045.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1988 by the American Society for Pharmacology and Experimental Therapeutics.